It’s fairly easy to get a CEO’s blood pressure spiking: just mention the two leading proxy advisers Institutional Shareholder Services and Glass Lewis. Some chief executives have accused these firms of fueling shareholder campaigns against them on a variety of topics, including pay practices, board independence, and how they should use their excess cash.
